Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
P D Berk

Abstract

No abstract listed.

References

Feb 1, 1978·The American Journal of Medicine·P D Berk, N B Javitt
Nov 28, 1979·Biochemical and Biophysical Research Communications·J Reichen, P D Berk
Nov 1, 1975·The Journal of Clinical Investigation·B F ScharschmidtP D Berk
Dec 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·F Kamp, J A Hamilton
Dec 1, 1991·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H OkudaP D Berk
May 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·P D BerkS Thung
Oct 8, 1990·Biochimica Et Biophysica Acta·C TiribelliG L Sottocasa
Nov 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·I R Wanless, J S Lentz
Jan 1, 1989·Annual Review of Nutrition·B J PotterP D Berk
Jan 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·W SchwietermanP D Berk
May 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·W Stremmel, P D Berk
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·W StremmelP D Berk
Jan 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·W StremmelP D Berk
Oct 1, 1973·Clinical Science and Molecular Medicine·J R BloomerN I Berlin
Oct 15, 1974·Biochemical Pharmacology·C Gisselbrecht, P D Berk
Oct 1, 1973·Clinical Science and Molecular Medicine·J R BloomerN I Berlin
Jan 1, 1974·The American Journal of Digestive Diseases·J R BloomerR B Howe
Sep 1, 1970·Clinica Chimica Acta; International Journal of Clinical Chemistry·J R BloomerN I Berlin
Feb 1, 1968·Annals of Internal Medicine·V BarrettN I Berlin
Nov 1, 1969·The Journal of Clinical Investigation·P D BerkN I Berlin
Apr 15, 1983·Biochemical and Biophysical Research Communications·W StremmelP D Berk
May 1, 1982·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J M VierlingB F Scharschmidt
Sep 19, 1995·Biochemistry·F KampJ A Hamilton
Oct 10, 1995·Proceedings of the National Academy of Sciences of the United States of America·L M IsolaP D Berk
Mar 1, 1995·Proceedings of the Society for Experimental Biology and Medicine·S L ZhouP D Berk

❮ Previous
Next ❯

Citations

Oct 13, 2009·Clinics in Liver Disease·Brent A Neuschwander-Tetri
Mar 24, 2016·BMC Complementary and Alternative Medicine·Hong ChangYong Wang
Aug 21, 2015·Frontiers of Medicine·Lixia GanLiqing Yu
Jan 29, 2013·Journal of Hepatology·Lars P BechmannScott L Friedman
Dec 17, 2011·Journal of Hepatology·Lars P BechmannAli Canbay
Mar 17, 2016·Annual Review of Pathology·Timothy HardyChristopher P Day
Nov 9, 2011·Laboratory Investigation; a Journal of Technical Methods and Pathology· YiminHitoshi Chiba
Jun 14, 2015·Expert Review of Gastroenterology & Hepatology·Francesca Romana PonzianiVeronica Ojetti
Jul 14, 2011·American Journal of Physiology. Endocrinology and Metabolism·Margarete DigelJoachim Füllekrug
Feb 8, 2018·Annual Review of Pathology·Juan Pablo ArabMichael Trauner
Jun 14, 2012·American Journal of Physiology. Endocrinology and Metabolism·Xabier BuquéPatricia Aspichueta
Feb 5, 2021·Circulation Research·Nada A AbumradIra J Goldberg
Jun 16, 2021·Atherosclerosis·Ira J GoldbergNada A Abumrad
Aug 28, 2021·Nutrients·João V S GuerraAna Carolina M Figueira

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.